Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK

Chemico-Biological Interactions

Volumn 103, Issue 3, 1997, Pages 153-166

  Murphy, Sharon E ^a,b   Nunes, Maria G ^a   Hatala, Mary Ann ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Glucuronides; Hepatocytes; Nitrosamines; NNK

Indexed keywords

3 METHYLCHOLANTHRENE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; DRUG METABOLITE; GLUCURONIDE; PHENOBARBITAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG METABOLISM; ENZYME INDUCTION; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; LIVER CELL; LUNG CANCER; MALE; NONHUMAN; OXIDATION; RAT; TOBACCO;

ANIMALS; BIOTRANSFORMATION; CARCINOGENS; CELLS, CULTURED; GLUCURONATES; HEMOGLOBINS; HYDROXYLATION; LIVER; MALE; METABOLIC DETOXICATION, DRUG; METHYLCHOLANTHRENE; MICROSOMES, LIVER; NITROSAMINES; OXIDATION-REDUCTION; PHENOBARBITAL; RATS; RATS, INBRED F344;

EID: 0031567149     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(96)03756-8     Document Type: Article

References (23)

1. [1] S.S. Hecht and D. Hoffmann, The relevance of tobacco-specific nitrosamines to human cancer, Cancer Surv., 8 (1989) 273-294.
2. [2] S.S. Hecht and D. Hoffmann, Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke, Carcinogenesis, 9 (1988) 875-884.
3. [3] A. Rivenson, D. Hoffmann, B. Prokopczyk, S. Amin and S.S. Hecht, Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines, Cancer Res., 48 (1988) 6912-6917.
4. [4] A. Castonguay, D. Lin, G.D. Stoner, P. Radok, K. Furuya, S.S. Hecht, H.A.J. Schut and J.E. Klaunig, Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues, Cancer Res., 43 (1983) 1223-1229.
5. [5] M.A. Morse, K.I. Eklind, M. Toussaint, S.G. Amin and F.-L. Chung, Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats, Carcinogenesis, 11 (1990) 1819-1823.
6. [6] S.S. Hecht, N. Trushin, C.A. Reid-Quinn, E.S. Burak, A.B. Jones, J.L. Southers, C.T. Gombar, S.G. Carmella, L.M. Anderson and J.M. Rice, Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the Patas monkey: pharmacokinetics and characterization of glucuronide metabolites, Carcinogenesis, 14 (1993) 229-236.
7. [7] S.G. Carmella, S. Akerkar and S.S. Hecht, Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine, Cancer Res., 53 (1993) 721-724.
8. [8] S.E. Murphy, D.A. Spina, M.G. Nunes and D.A. Pullo, Glucuronidation of 4-(hydroxymethyl)nitrosamino-1-(3-pyridyl)-1-butanone, a metabolically activated form of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), by phénobarbital treated rats, Chem. Res. Toxicol., 8 (1995) 772-779.
9. [9] Z. Guo, T.J. Smith, P.E. Thomas and C.S. Yang, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats, Arch. Biochem. Biophys., 298 (1992) 279-286.
10. [10] T. Tephly, Isolation and purification of UDP-glucuronosyltransferases, Chem. Res. Toxicol., 3 (1990) 509-516.
11. [11] P. Styczynski, M. Green, J. Puig, B. Coffman and T. Tephly, Purification and properties of a rat liver Phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase, Mol. Pharmacol., 40 (1991) 80-84.
12. [12] T.R. Tephly and B. Burchell, UDP-glucuronosyltransferases: a family of detoxifying enzymes, Trends Pharmacol. Sci., 11 (1990) 276-279.
13. [13] K. Wiench, E. Frie, P. Schroth and M. Wiessler, 1-C-Glucuronidation of N-nitrosodiethylamine and N-nitrosomethyl-n-pentylamine in vivo and in primary hepatocytes from rats pretreated with inducers, Carcinogenesis, 13 (1992) 867-872.
14. [14] L. Ehrenberg and S. Osterman-Golkar, Alkylation of macromolecules for detecting mutagenic agents, Teratog. Carcinog. Mutag. 1 (1980) 105-127.
15. [15] S.G. Carmella, S.S. Kagan, M. Kagan, P.G. Foiles, G. Palladino, A.M. Quart, E. Quart and S.S. Hecht, Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers, Cancer Res., 50 (1990) 5438-5445.
16. [16] S.S. Hecht, S.G. Carmella and S.E. Murphy, Tobacco-specific nitrosamine-hemoglobin adducts, in: J. Everse, R.M. Winston, and K.D. Vandegriff, (Eds.) Methods in Enzymology, Hemoglobins, Part B: Biochemical and Analytical Methods, Vol 231, Academic Press, San Diego, CA, 1994, pp. 657-667.
17. [17] S.E. Murphy, A. Palomino, S.S. Hecht and D. Hoffmann, Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats, Cancer Res., 50 (1990) 5446-5452.
18. [18] G.M. Williams, E. Bermudez and D. Scaramuzzino, Rat hepatocyte primary cell cultures. III: improved dissociation and attachment techniques and the enhancement of survival by culture medium, in Vitro, 13 (1977) 809-817.
19. [19] S.E. Murphy, S. Amin, K. Coletta and D. Hoffmann, Metabolism of benzo[b]naphtho[2,1-D]-thiophene by F344 rats, Chem. Res. Toxicol., 5 (1991) 491-492.
20. [20] S.G. Carmella and S.S. Hecht, Formation of hemoglobin adducts upon treatment of F344 rats with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitro-sonornicotine, Cancer Res., 47 (1987) 2626-2630.
21. [21] L.A. Peterson, R. Mathew and S.S. Hecht, A study of chemical carcinogenesis, 142: quantitation of microsomal α-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, Cancer Res., 51 (1991) 5495-5500.
22. [22] S.G. Carmella, S.S. Kagan and S.S. Hecht, Evidence that a hemoglobin adduct of 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone is a 4-(3-pyridyl)-4-oxobutyl carboxylic acid ester, Chem. Res. Toxicol., 5 (1992) 77-80.
23. [23] R. Steward, G.A. Dannan, P.S. Guzelian and F.P. Guengerich, Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes, Mol. Pharmacol., 27 (1984) 125-132.